Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kelli L. Goss
mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
mTORC1 and DNA-PKcs as Novel Molecular Determinants of Sensitivity to Chk1 Inhibition
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Tumour Growth Environment Modulates Chk1 Signalling Pathways and Chk1 Inhibitor Sensitivity
Scientific Reports
Multidisciplinary
Simultaneous Exposure of Transformed Cells to SRC Family Inhibitors and CHK1 Inhibitors Causes Cell Death
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Chk1 and Mps1 Jointly Regulate Correction of Merotelic Kinetochore Attachments
Journal of Cell Science
Cell Biology
γH2AX and Chk1 Phosphorylation as Predictive Pharmacodynamic Biomarkers of Chk1 Inhibitor-Chemotherapy Combination Treatments
BMC Cancer
Cancer Research
Oncology
Genetics
ATR and DNA-PK/CHK1 Elicit Distinct Responses in Cancer Cells
Cancer Discovery
Oncology
Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional P53
Molecular Cancer Therapeutics
Cancer Research
Oncology
Analysis of Rad3 and Chk1 Protein Kinases Defines Different Checkpoint Responses
EMBO Journal
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
Ciclopirox Activates ATR-Chk1 Signaling Pathway Leading to Cdc25A Protein Degradation
Genes and Cancer
Cancer Research
Genetics